Skip to main content Skip to search Skip to main navigation

How do we deal with risks?

Whether in the professional or private environment – risks accompany us in all situations in life. Dealing with these risks is generally based on knowledge and experience. A methodical approach transforms the individualised handling of risks into structured risk management. On the other hand, disadvantages for the individual, the company and patient protection outweigh the risks in situations where risks are dismissed as a trivial matter or ignored.

[GMP Compliance Adviser, 19.A]


 

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: New Q&A on Product Lifecycle Management (PLCM)

EMA: New Q&A on Product Lifecycle Management (PLCM)

The EMA has published new Questions & Answers on the use of the Product Lifecycle Management (PLCM) document, clarifying its role within the EU variations framework for post-approval quality changes.
Read more
EMA: New Q&A for Co-Processed Excipients

EMA: New Q&A for Co-Processed Excipients

The EMA has published new Questions & Answers on co-processed excipients (CoPEs) used in solid oral dosage forms, introducing a harmonised, risk-based regulatory approach applicable to human and veterinary medicines.

Read more
What is the Data Lifecycle?

What is the Data Lifecycle?

Here's the answer:
Read more
Previous
Next